Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Javier, Soto Alsar"'
Autor:
Javier Soto Alsar, Roberto Jiménez Rodríguez, Ana Gutiérrez, Laura Ortega Morán, Andrés J. Muñoz Martín
Publikováno v:
Thrombosis Update, Vol 16, Iss , Pp 100183- (2024)
Cancer-associated thrombosis is a common problem in cancer patients and one of the leading causes of death in this population. Randomised clinical trials have shown that both low-molecular-weight heparins and direct oral anticoagulants are the treatm
Externí odkaz:
https://doaj.org/article/c0f5d63703ca4aa9a6317998b2f96000
Autor:
Pilar García-Alfonso, Andrés Jesús Muñoz Martín, Laura Ortega Morán, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Montserrat Blanco Codesido, Pilar Aitana Calvo Ferrandiz, Silvina Grasso Cicala
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Colorectal cancer (CRC) is one of the most common forms of cancer, with an estimated 1.36 million new cases and almost 700,000 deaths annually. Approximately 21% of patients with CRC have metastatic disease at diagnosis. The objective of this article
Externí odkaz:
https://doaj.org/article/344cd31c70874b66a91affaa308d000e
Autor:
Javier Soto Alsar, Ana Gutiérrez Ortiz de la Tabla, Laura Ortega Morán, Andrés J. Muñoz Martín
Publikováno v:
Best practiceresearch. Clinical haematology. 35(1)
Anticoagulation is the cornerstone of cancer-associated VTE treatment, including vitamin K antagonists (VKA), unfractionated heparin (UFH), fondaparinux, low-molecular-weight heparins (LMWH) and direct oral anticoagulants (DOACs). The goals of antico
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c05de31fc0b62769a6e482d2a62f7990
https://pubmed.ncbi.nlm.nih.gov/36030074
https://pubmed.ncbi.nlm.nih.gov/36030074
Autor:
César, Gutiérrez Pérez, Irene, Chivato Martín-Falquina, Inmaculada, Rodríguez Ledesma, Alicia, Cuenca Zarzuela, Javier, Soto Alsar, David Salomón, Juliao Caamaño, Roberto, Jiménez Rodríguez, Carlos, García Girón
Publikováno v:
Revista Española de Enfermedades Digestivas.
We bring forward a case of a 58-year-old female who, undergoing treatment for glioblastoma with temozolomide and radiotherapy, visited the Emergency Department due to acute abdominal pain and chemotherapy-induced febrile neutropenia. She was diagnose
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78f05e80521e711e4f43b387ba91392c
https://doi.org/10.17235/reed.2022.9009/2022
https://doi.org/10.17235/reed.2022.9009/2022
Autor:
Rocío Martín Lozano, Roberto Jiménez Rodríguez, Irene Gonzalez Caraballo, Bárbara Lobato Delgado, María Palma Gómez, Marc Ariant Cañete Muñoz, Mónica Benavente de Lucas, Carlos López Jiménez, Victoria Tirado Anula, Blanca Morón García, María de Toro Carmena, Marianela Bringas Beranek, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Aitana Calvo, Laura Ortega, Jose Manuel Soria, Pilar Garcia-Alfonso, Miguel Martin, Andrés J. Muñoz Martín
Publikováno v:
Journal of Clinical Oncology. 41:740-740
740 Background: Several inflammatory scores such as the Systemic Inflammation Response Index (SIRI), the Inflammation Index Score (IIS), and the Neutrophil Lymphocyte Ratio (NLR) have been reported to have prognostic value in PDAC with different resu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36d0485dcbd175b20da5d4ba4fa137d6
https://doi.org/10.1200/jco.2023.41.4_suppl.740
https://doi.org/10.1200/jco.2023.41.4_suppl.740
Autor:
Andres J. Muñoz Martín, Javier Soto Alsar, Gabriela Torres Pérez-Solero, Pilar García-Alfonso, Javier Parrondo
Publikováno v:
Clinical Case Reports and Reviews. 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f755f4b9cde6b5c2c37f92de547bb7dc
https://doi.org/10.15761/ccrr.1000508
https://doi.org/10.15761/ccrr.1000508
Autor:
Pilar Garcia-Alfonso, Natalia Gutiérrez Alonso, Marianela Bringas Beranek, Javier Soto Alsar, Carlos López Jiménez, Ana Gutierrez Ortiz de la Tabla, Roberto Jiménez Rodríguez, Rocío Martín Lozano, César Gutiérrez Pérez, Manuel Alva Bianchi, Andrés J. Muñoz Martín, Gabriela Torres Pérez-Solero, Laura Ortega, Aitana Calvo Ferrándiz, Juan Luis Catoya Villa, Marta Arregui Valles, Inmaculada Aparicio Salcedo, Miguel Martin
Publikováno v:
Journal of Clinical Oncology. 40:e15552-e15552
e15552 Background: BRAF mutated mCRC patients have worse prognosis compared with BRAF wildtype mCRC. Within this group, those with resectable disease have a better prognosis compared to those with unresectable disease. However, it is not well known w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3cb5c3c9544c8385ff9e6f4ac79b502f
https://doi.org/10.1200/jco.2022.40.16_suppl.e15552
https://doi.org/10.1200/jco.2022.40.16_suppl.e15552
Autor:
Laura Ortega Morán, Pilar Aitana Calvo Ferrandiz, Gabriela Torres Pérez-Solero, Pilar García-Alfonso, Montserrat Blanco Codesido, Andres J. Muñoz Martín, Silvina Grasso Cicala, Javier Soto Alsar
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Colorectal cancer (CRC) is one of the most common forms of cancer, with an estimated 1.36 million new cases and almost 700,000 deaths annually. Approximately 21% of patients with CRC have metastatic disease at diagnosis. The objective of this article
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99a279b119e717f3fed01ff4998ccb68
https://pubmed.ncbi.nlm.nih.gov/33995592
https://pubmed.ncbi.nlm.nih.gov/33995592
Autor:
Javier Soto Alsar, Andres J. Muñoz Martín, Gonzalo García González, Aitana Calvo Ferrándiz, Marta Arregui Valles, Pilar García-Alfonso, Manuel Alva Bianchi, Marianela Bringas Beranek, Miguel Martín, Gabriela Torres Pérez-Solero, Inmaculada Aparicio Salcedo, Montserrat Blanco-Codesido, Laura Ortega, Iria Gallego Gallego, Natalia Gutiérrez Alonso
Publikováno v:
Journal of Clinical Oncology. 38:4041-4041
4041 Background: Approximately 25% of patients with colorectal cancer (CRC) debut with metastatic disease. In addition, 25-35% of patients with localized disease at diagnosis develop metastatic lesions during the evolution of their disease. Consequen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4c5fa3ef4c483ce926fcb4bfe1f9e986
https://doi.org/10.1200/jco.2020.38.15_suppl.4041
https://doi.org/10.1200/jco.2020.38.15_suppl.4041
Autor:
Íñigo Martínez Delfrade, Natalia Gutiérrez Alonso, Javier Soto Alsar, Gema Aguado Orihuela, Blanca Morón García, Montserrat Blanco-Codesido, Iria Gallego Gallego, Laura Ortega Morán, Carmen Sandoval García, Aitana Calvo Ferrándiz, Victoria Tirado Anula, Marianela Bringas Beranek, Pilar García-Alfonso, Andres J. Muñoz Martín, Gonzalo García González, María de Toro Carmena, Gabriela Torres Pérez-Solero, Iker Aguilar Caballero, Miguel Martín
Publikováno v:
Journal of Clinical Oncology. 37:e15136-e15136
e15136 Background: A recent study has suggested that KRAS mutation could increase the risk of VTE in patients with CRC. The role of others biomarkers, such as BRAF, in this setting is unknown. The aim of this study is to analyze the incidence of canc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1fd6049abe5c6e34b77258f2845bf2c
https://doi.org/10.1200/jco.2019.37.15_suppl.e15136
https://doi.org/10.1200/jco.2019.37.15_suppl.e15136